• News
  • Health

Two labs sign with Critical Diagnostics

San Diego-based Critical Diagnostics announced Thursday an agreement with Quest Diagnostics (NYSE: DGX) and Berkeley HeartLab under which both Quest and Berkeley will offer ST2 testing services based on Critical Diagnostics’ Presage ST2 Assay.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!